Progyny, Inc. Total Liabilities
Progyny, Inc. (PGNY) had Total Liabilities of $262.58 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-07
- 2026-06-30: Liabilities $262.58M.
- 2026-03-31: Liabilities $258.99M.
- 2025-12-31: Liabilities $226.39M.
- 2025-09-30: Liabilities $235.22M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $262.58M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $258.99M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $226.39M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $235.22M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $245.93M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $263.13M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $185.04M 10-K · filed 2026-02-27 |
| 2024-09-30 | $225.10M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $242.44M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $222.70M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $203.19M 10-K · filed 2025-03-03 |
| 2023-09-30 | $211.12M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $212.04M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $225.32M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $166.02M 10-K · filed 2024-02-29 |
| 2022-09-30 | $163.59M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $151.85M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $135.91M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $106.24M 10-K · filed 2023-03-01 |
| 2021-09-30 | $112.57M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $107.53M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $109.97M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $86.98M 10-K · filed 2022-03-01 |
| 2020-09-30 | $74.78M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $57.99M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $59.06M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $36.16M 10-K · filed 2021-03-01 |
| 2019-09-30 | $57.56M 10-Q · filed 2019-12-06 |
| 2018-12-31 | $30.20M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |